The effect of various zinc binding groups on inhibition of histone deacetylases 1-11. (Q39283136)

10 September 2017

The effect of various zinc binding groups on inhibition of histone deacetylases 1-11. (English)

1 reference

10 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Christian A. Olsen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Helle M E Kristensen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Gyrithe Lanz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

27 December 2013

1 reference

10 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

614-626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375963%20AND%20SRC:MED&resulttype=core&format=json

Chromatin modifications and their function

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Chemical phylogenetics of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Substrate and functional diversity of lysine acetylation revealed by a proteomics survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Lysine acetylation targets protein complexes and co-regulates major cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Regulation of cellular metabolism by protein lysine acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Identification of lysine succinylation as a new post-translational modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

An epigenetic blockade of cognitive functions in the neurodegenerating brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Small molecule inhibitors of zinc-dependent histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Inside HDAC with HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Histone deacetylase inhibitors: from bench to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Investigating the selectivity of metalloenzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

A series of novel, potent, and selective histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Sulfamides as novel histone deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Structural Biasing Elements for In-Cell Histone Deacetylase Paralog Selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Total synthesis and molecular target of largazole, a histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Thiol-based SAHA analogues as potent histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Trifluoromethyl ketones as inhibitors of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Alpha-keto amides as inhibitors of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Crystal structure of a bacterial class 2 histone deacetylase homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Stereocontrolled synthesis of methyl silanediol peptide mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Sequential C-Si bond formations from diphenylsilane: application to silanediol peptide isostere precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Organosilicon molecules with medicinal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Pd(II)-catalyzed amination of C-H bonds using single-electron or two-electron oxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Trifluoromethyl ketones from enolizable carboxylic acids via enediolate trifluoroacetylation/decarboxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

A structure-based design approach to the development of novel, reversible AChE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Heterologous reconstitution of the intact geodin gene cluster in Aspergillus nidulans through a simple and versatile PCR based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Inhibition of pheromone action inSesamia nonagrioidesby Haloacetate analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

Expansion of the lysine acylation landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Zinc binding in HDAC inhibitors: a DFT study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Silanediols: A New Class of Potent Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Efficient routes to carbon-silicon bond formation for the synthesis of silicon-containing peptides and azasilaheterocycles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Quantum chemical study of silanediols as metal binding groups for metalloprotease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Synthesis and properties of a sterically unencumbered δ-silanediol amino acid

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Synthesis of 5-bromopyridyl-2-magnesium chloride and its application in the synthesis of functionalized pyridines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Total Synthesis and Full Histone Deacetylase Inhibitory Profiling of Azumamides A–E as Well as β2- epi-Azumamide E and β3-epi-Azumamide E

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021

Regioselective intramolecular oxidation of phenols and anisoles by dioxiranes generated in situ

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300433

7 January 2021